GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Autodesk, Inc. (ADSK) [hlAlert]

Rating:
Equal Weight
ADSK
up 35.09 %

Autodesk, Inc. (ADSK) rated Equal Weight with price target $45 by Barclays

Posted on: Thursday,  Oct 3, 2013  1:25 PM ET by Barclays

Barclays rated Equal Weight Autodesk, Inc. (NASDAQ: ADSK) on 10/03/2013. Previously Barclays rated Overweight Autodesk, Inc. (NASDAQ: ADSK) on 05/17/2013.,
when the stock price was $37.01. Since then, Autodesk, Inc. has gained 35.10% as of 11/20/2015's recent price of $50.00.
If you would have followed the previous Barclays's recommendation on ADSK, you would have gained 35.09% of your investment in 917 days.

Acadia Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. Their three clinical programs are ACP-103 for treatment-induced dysfunction in Parkinson?s disease, and ACP-104 and ACP-103, both for the treatment of schizophrenia.

Barclays
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/20/2015 1:25 PM Buy
None
60.29 70.00
as of 12/13/2013
1 Week up  2.84 %
1 Month up  9.64 %
3 Months up  25.03 %
1 YTD up  14.18 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/20/2015 2:25 PM Buy
None
57.47 68.00
7/10/2014 12:00 AM Buy
None
55.44 65.00
10/3/2013 1:25 PM Buy
None
41.81 45.00
5/17/2013 1:25 PM Buy
None
37.08 40.00
5/17/2013 12:25 PM Buy
None
37.01 98.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy